Permeability of alginate microcapsules to secretory recombinant gene products

Biotechnology and Bioengineering

Volumn 52, Issue 4, 1996, Pages 472-484

  Awrey, D E ^a   Tse, M ^a   Hortelano, G ^a   Chang, P L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

albumin; gene therapy; growth hormone; immunoglobulin; lysosomal enzymes

Indexed keywords

ANIMAL CELL CULTURE; CELL MEMBRANES; COATINGS; ENZYME KINETICS; GENES; IMMUNOLOGY; MECHANICAL PERMEABILITY; MOLECULAR WEIGHT; PHYSIOLOGICAL MODELS;

ALGINATE MICROCAPSULES; GROWTH HORMONES; IMMUNOGLOBULIN; LYSOZOMAL ENZYMES; NON AUTOLOGOUS SOMATIC GENE THERAPY; SECRETORY RECOMBINANT GENE PRODUCTS;

GENETIC ENGINEERING;

ALGINIC ACID; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; CEREBROSIDE SULFATASE; GENE PRODUCT; HUMAN GROWTH HORMONE; HUMAN IMMUNOGLOBULIN; POLYLYSINE; SERUM ALBUMIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SECRETION; CELL VIABILITY; CONTROLLED STUDY; GENE THERAPY; MEMBRANE PERMEABILITY; MICROCAPSULE; MOUSE; NONHUMAN; RECOMBINANT DNA TECHNOLOGY;

ANIMALIA;

EID: 10244257590     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19961120)52:4<472::AID-BIT3>3.0.CO;2-M     Document Type: Article

References (48)

1. Aebischer, P., Goddard, M., Tresco, P. A. 1993. Cell encapsulation for the nervous system, pp. 197-224. In: M. F. A. Goosen (ed.), Fundamentals of animal cell encapsulation. CRC Press, Boca Raton, FL.
2. Al-Hendy, A., Hortelano, G., Tannenbaum, G., chang, P. L. 1995. Allogeneic somatic gene therapy: Correction of growth hormone deficiency in dwarf mice with micro-encapsulated non-autologous myoblasts. Hum. Gene Ther. 6: 165-175.
3. Asubel, F. M., Brent, R., Kingston, R. E., Mugie, O. D., Seidman, J. G., Smith, J. A., Struhl, K. (eds.). 1989. Current protocols in molecular biology. John Wiley & Sons, New York.
4. Awrey, D. 1993. Secretion of marker proteins from alginate-poly-L-lysine-alginate microcapsules. M.Sc. thesis, McMaster University, Hamilton. Ontario, Canada.
5. Baum, H., Dodgson, K. S., Spencer, B. 1959. The assay of arylsulphatases A and B in human urine. Clin. Chim. Acta 4: 453-455.
6. Chang, P. L., Capone, J. P., Brown, G. M. 1990. Autologous fibroblast implanation - feasibility and potential problems in gene replacement therapy. Mol. Biol. Med. 7: 462-470.
7. Chang, P. L., Shen, N., Westcott, A 1993. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4: 433-440.
8. Chang, P. L. 1994. Calcium phosphate-mediated DNA transfection, pp. 157-179. In: J. A. Wolff (Ed.), Gene therapeutics. Birkhäuser, Boston, MA.
9. Chang, P. L., Hortelano, G., Tse, M., Awrey, D. E. 1994. Growth of recombinant fibroblasts in alginate microcapsules. Biotechnol. Bioeng. 43: 925-933.
10. Chang, P. L. 1995. Nonautologous somatic gene therapy, pp. 203-223. In: P. L. Chang (ed.), Somatic gene therapy. CRC Press, Boca Raton, FL.
11. Chang, T. M. S., 1964. Semi-permeable microcapsules. Science 146: 524-525.
12. Chang, T. M. S., MacIntosh, F. C., Mason, S. G. 1966. Semipermeable aqueous microcapsules. Can. J. Physiol. Pharmacol. 44: 115-128.
13. Gabel, C. A., Goldberg, D. E., Kornfeld, S. 1983. Identification and characterization of cells deficient in the mannose 6-phosphate receptor. evidence for an alternate pathway for lysosomal enzyme targeting. Proc. Natl. Acad. Sci. USA 80: 775-779.
14. Glaser, J. H., Sly, W. S. 1973. β-Glucuronidase deficiency mycopolysaccharidosis: Methods for enzymatic diagnosis. J. Lab. Clin. Med. 82: 969-977.
15. Goosen, M. F. A. 1987. Insulin delivery systems and the encapsulation of cells for medical and industrial use. CRC Crit. Rev. Biocompat. 3: 1-24.
16. Goosen, M. F. A., O'Shea, G. M., Gharapetian, H., Chou, S., Sun, A. M. 1985. Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas. Biotechnol. Bioeng. 27: 146-150.
17. Graham, F. L., Bacchetti, S. 1983. DNA mediated gene transfer using the calcium technique. Nucl. Acid Biochem. B506: 1-14.
18. M2 gangliosidoses, chap. 92. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, (eds.), The metabolic and molecular bases of inherited disease. McGraw-Hill, New York.
19. Hortelano, G., Al-Hendy, A., Ofosu, F. A., Chang, P. L. 1996. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood, to appear.
20. Hughes, M., Vassilakos, A., Andrews, D. W., Hortelano, G., Belmont, J. W., Chang, P. L. 1994. Delivery of a secretable adenosine deaminase through microcapsules - a novel approach to somatic gene therapy. Hum. Gene Ther. 5: 1445-1455.
21. Jarvis, A. P., Jr., Grdina, T. A. 1983. Production of biologicals from microencapsulated living cells. Biotechniques 1: 17-22.
22. King, G. A., Daugulis, A. J., Faulkner, P., Goosen, M. F. A. 1987. Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotechnol. Prog. 3: 231-240.
23. Lacy, P. E., Hegre, O. D., Gerasimidi-Vazeou, A., Gentile, F. T., Dionne, K. E. 1991. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254: 1782-1784.
24. Lee, S.-J., Nathans, D. 1988. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J. Biol. Chem. 263: 3521-3527.
25. Li, C. H. 1957. Properties of and structural investigations on growth hormone isolated from bovine, monkey and human pituitary glands. Fed. Proc. 16: 775-783.
26. Lim, F., Sun, A. M. 1980. Microencapsulaled islets as bioartificial endocrine pancreas. Science 210: 908-910.
27. Lin, C., Lin, S., Chang, C., Rosenfeld, M. G. 1992. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360: 765-768.
28. Liu, H., Ofosu, F. A., Chang, P. L. 1993. Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum. Gene Ther. 4: 291-301.
29. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
30. Marshall, E. 1995. Gene therapy's growing pains. Science 269: 1050-1055.
31. Nichol, L. W., Roy, A. B. 1965. The polymerisation of sulfatase A. Biochemistry 4: 386-396.
32. Oda, K., Takami, N., Fugiwara, T., Misumi, Y., Ikehara, Y. 1989. Proalbumin is processed to serum albumin in Cos-1 cells transfected with cDNA for rat albumin. Biochem. Biophys. Res. Commun. 163: 194-200.
33. Okada, S., O'Brien, J. S. 1969. Tay-Sachs disease. Generalized absence of a beta-D-N-acetylhexosaminidase component. Science 165: 698-700.
34. Okhamafe, A. O., Goosen, M. F. A. 1993. Control of membrane permeability in microcapsules, pp. 55-78. In: M. F. A. Goosen (ed.), Fundamentals of animal cell encapsulation and immobilization, CRC Press, Boca Raton, FL.
35. O'Shea, G. M., Goosen, M. F. A., Sun, A. M. 1984. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta 804: 133-136.
36. Palmour, R. M., Goodyer, P., Reade, T., Chang, T. M. S. 1989. Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan disease. Lancet, Sept. 16: 687-688.
37. Phillips, H. J. 1973. Dye exclusion tests for cell viability, pp. 406-408. In: P. F. Kruse and M. K. Patterson (eds.), Tissue culture methods and applications. Academic Press, New York.
38. Schultze, H. E., Heremans, J. F. 1966. Molecular biology of human proteins. Elsevier, Amsterdam.
39. Southern, P. J., Berg, P. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Molec. Appl. Genet. 1: 327-341.
40. Stein, C., Gieselmann, V., Kreysing, J., Schmidt, B., Pohlmann, R., Waheed, A., Meyer, H. E., O'Brien, J. S., von Figura, I. 1989. Cloning and expression of human arylsulfatase. A. J. Biol. Chem. 264: 1252-1259.
41. Sun, A. M. 1988. Microencapsulation of pancreatic islet cells: A bioartificial endocrine pancreas. Meth. Enzymol. 137: 575-579.
42. Sun, A. M., Cai, Z., Shi, Z., Ma, F., O'Shea, G. M., Gharapetian, H. 1986. Microencapsulated hepatocytes as a bioartificial liver. Trans. Am. Soc. Artif. Intern. Organs. 32: 39-41.
43. Sun, A. M., O'Shea, G. M. Microencapsulation of living cells - a long-term delivery system. J. Controlled Release 2: 137-141.
44. Tomino, S., Paigen, K. 1975. Purification and chemical properties of mouse liver lysosomal (L-form) β-glucuronidase. J. Biol. Chem. 250: 8503-8509.
45. Tse, M., Uludag, H., Sefton, M. V., Chang, P. L. 1966. Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules. Biotechnol. Bioeng., to appear.
46. Tyn, M. T., Gusek, T. W. 1990. Prediction of diffusion coefficients of proteins. Biotechnol. Bioeng. 35: 327-338.
47. Wong, H., Chang, T. M. S. 1988. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomat. Art. Cells Art. Org. 16: 731-739.
48. Yuet, P., Kwok, W., Harris, T. J., Goosen, M. F. A. 1993. Mathematical modeling of protein diffusion and cell growth in microcapsules, pp. 79-111. In: M. F. A. Goosen (ed.), Fundamentals of animal cell encapsulation and immobilization. CRC Press, Boca Raton, FL.